Edward J Dulac III's Net Worth
$3.41 Million
Who is Edward J Dulac III?
Edward J Dulac III has an estimated net worth of $3.41 Million. This is based on reported shares across multiple companies, which include FATE THERAPEUTICS INC, and Intellia Therapeutics, Inc..
SEC CIK
Edward J Dulac III's CIK is 0001821530
Past Insider Trading and Trends
2021 was Edward J Dulac III's most active year for acquiring shares with 5 total transactions. Edward J Dulac III's most active month to acquire stocks was the month of December. 2021 was Edward J Dulac III's most active year for disposing of shares, totalling 7 transactions. Edward J Dulac III's most active month to dispose stocks was the month of December. 2021 saw Edward J Dulac III paying a total of $1,128,186.24 for 116,166 shares, this is the most they've acquired in one year. In 2021 Edward J Dulac III cashed out on 70,673 shares for a total of $2,482,056.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FATE THERAPEUTICS INC (FATE) Snapshot price: $3.41
Chief Financial OfficerEdward J Dulac III owns 101,479 units of Common stock which is worth $346,043.39. In the year 2024 Edward J Dulac III filed a total of 20 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.35% | -2.45K |
$7.77 | -$19,013.19 | 101.48K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| -1.75% | -1.85K |
$5.00 | -$9,245.00 | 103.93K |
Jan 29
| |||
Form 4
| -6.23% | -7.03K |
$4.37 | -$30,712.36 | 105.78K |
Jan 9
| |||
Form 4
| -4.39% | -5.18K |
$3.66 | -$18,966.12 | 112.8K |
Jan 2
| |||
Form 4
| -1.33% | -1.58K |
$3.50 | -$5,547.50 | 117.98K |
Scheduled
|
Dec 18
| ||
Form 4
| -3.80% | -4.72K |
$2.80 | -$13,210.40 | 119.57K |
Aug 18
| |||
Form 4
| -4.00% | -5.18K |
$4.83 | -$25,029.06 | 124.29K |
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| -5.36% | -7.33K |
$5.24 | -$38,414.44 | 129.47K |
Jan 10
| |||
Form 4
| -3.62% | -5.13K |
$29.81 | -$153,051.37 | 136.8K |
Aug 18
| |||
Form 4
| +30.66% | 33.3K |
—
|
—
| 141.94K |
Jan 25
| |||
Form 4
| -1.60% | -1.77K |
$48.45 | -$85,757.40 | 108.63K |
Jan 11
| |||
Form 4
| -1.38% | -1.54K |
$47.76 | -$445,817.76 | 110.4K |
Scheduled
|
Dec 20
| ||
Form 4
| +113.62% | 59.54K |
—
|
—
| 111.94K |
Nov 19
| |||
Form 4
| -3.91% | -2.13K |
$49.03 | -$601,449.80 | 52.4K |
Scheduled
|
Sep 28
| ||
Form 4
| -5.99% | -3.47K |
$88.26 | -$306,602.40 | 54.54K |
Aug 19
| |||
Form 4
| +45.03% | 18.01K |
—
|
—
| 58.01K |
Jan 20
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
EVP, Chief Financial OfficerEdward J Dulac III owns 66,324 units of Common Stock which is worth $1,309,899.00. In the year 2024 Edward J Dulac III filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 66.32K |
—
|
—
| 66.32K |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||